Dhruv Khullar

A new book argues that many of the world’s oldest people aren’t so old after all.

The outbreaks of hantavirus and Ebola expose the shortsightedness of America’s retreat, under the Trump Administration, from its role as a global-health leader.

Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health of consumers—is at stake.

GLP-1 drugs, which have helped some people curb drug and alcohol use, may unlock a pathway to moderation.

It’s as if the show’s creators absorbed every important conversation in health care today—and somehow transfigured it into good television.

Some patients don’t trust us. Others say they don’t need us. It’s time for us to think of ourselves not as the high priests of health care but as what we have always been: healers.

The Department of Health and Human Services maintains that it is hewing to “gold standard, evidence-based science”—doublespeak that might unsettle Orwell.

As confidence in the C.D.C. wanes, states are asserting more control over their vaccine policies, creating a fragmented public-health system.

Large language models are transforming medicine—but the technology comes with side effects.

When MAGA met MAHA, Donald Trump vowed that Kennedy would “go wild on health.” Promises made, promises kept.